CIBC World Market’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
JSAM
AT
AWC
MIM
CIBC World Market's PPH Position: Q2 2026 in Review
CIBC World Market increased its VanEck Pharmaceutical ETF (PPH) stake by 18% in Q2 2026, buying an estimated $98.1K and bringing the position to 6,336 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.
CIBC World Market first reported a position in PPH in Q2 2022 and has held it in 13 quarters since. The position peaked at $2.2M in Q3 2024. 117 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- CIBC World Market held 6,336 shares of VanEck Pharmaceutical ETF worth $693K as of Q2 2026.
- CIBC World Market bought 948 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $98.1K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1113 holding.
- CIBC World Market first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and has held it in 13 quarters since.
- CIBC World Market's VanEck Pharmaceutical ETF position peaked at $2.2M in Q3 2024.
- 117 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.